Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- NCT ID
- NCT04751396
- Registry status
- Recruiting
- Study type
- Observational
- Sponsor
- M.D. Anderson Cancer Center
- Conditions
- Ankylosing Spondylitis, Autoimmune Disease, Crohn Disease, Enteropathic Arthritis, Enteropathic Spondylitis, Inflammatory Bowel Disease, Melanoma, Psoriasis, Psoriatic Arthritis, Reactive Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ulcerative Colitis
Overview
ClinicalTrials.gov lists this study as Recruiting.
Official title: Testing of an Educational Tool for Patients With Melanoma and Concomitant Autoimmune Disease Who Are Candidates for Adjuvant Therapy With Immune Checkpoint Inhibitors: Acceptability and Usability With Patients and Providers
Enrollment: 125 participants (Estimated).
What is being studied
- Other: Best Practice
- Intervention: Child Health Services
- Intervention: Community Health Services
- Intervention: Data Collection
- Intervention: Early Intervention, Educational
- Other: Educational Intervention
- Intervention: Educational Status
- Intervention: Environment and Public Health
- Intervention: Epidemiologic Methods
- Intervention: Guidelines as Topic
- Intervention: Health Care Evaluation Mechanisms
- Intervention: Health Care Facilities Workforce and Services
- Intervention: Health Care Quality, Access, and Evaluation
- Intervention: Health Services
- Intervention: Health Services Administration
- Other: Interview
- Intervention: Interviews as Topic
- Intervention: Investigative Techniques
- Intervention: Methods
- Intervention: Population Characteristics
- Intervention: Practice Guidelines as Topic
- Intervention: Preventive Health Services
- Intervention: Public Health
- Intervention: Quality Assurance, Health Care
- Intervention: Quality Indicators, Health Care
- Intervention: Quality of Health Care
- Other: Questionnaire Administration
- Intervention: Socioeconomic Factors
- Intervention: Standard of Care
- Other: Survey Administration
Who may be eligible
- Ages
- 18 Years to no maximum
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.
Countries: United States
- Texas, United States: 1
Sample of listed locations
- M D Anderson Cancer Center — Houston, Texas, 77030, United States — Recruiting
Study details
- Start date
- April 20, 2022
- Primary completion date
- February 2, 2027
- Completion date
- February 2, 2027
- First posted
- February 12, 2021
- Collaborators
- National Cancer Institute (NCI)
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT04751396
- Registry last updated
- May 20, 2026
- QualifiedStudies registry data refreshed
- October 2, 2026
- QualifiedStudies record fetched
- October 2, 2026
View NCT04751396 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Clinical trial FAQ